Lipid Laboratory, Endocrinology Unit, Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.
Diabetes. 2022 Jun 1;71(6):1350-1362. doi: 10.2337/db21-0804.
Interindividual differences in generation of new fat cells determine body fat and type 2 diabetes risk. In the GENetics of Adipocyte Lipolysis (GENiAL) cohort, which consists of participants who have undergone abdominal adipose biopsy, we performed a genome-wide association study (GWAS) of fat cell number (n = 896). Candidate genes from the genetic study were knocked down by siRNA in human adipose-derived stem cells. We report 318 single nucleotide polymorphisms (SNPs) and 17 genetic loci displaying suggestive (P < 1 × 10-5) association with fat cell number. Two loci pass threshold for GWAS significance, on chromosomes 2 (lead SNP rs149660479-G) and 7 (rs147389390-deletion). We filtered for fat cell number-associated SNPs (P < 1.00 × 10-5) using evidence of genotype-specific expression. Where this was observed we selected genes for follow-up investigation and hereby identified SPATS2L and KCTD18 as regulators of cell proliferation consistent with the genetic data. Furthermore, 30 reported type 2 diabetes-associated SNPs displayed nominal and consistent associations with fat cell number. In functional follow-up of candidate genes, RPL8, HSD17B12, and PEPD were identified as displaying effects on cell proliferation consistent with genetic association and gene expression findings. In conclusion, findings presented herein identify SPATS2L, KCTD18, RPL8, HSD17B12, and PEPD of potential importance in controlling fat cell numbers (plasticity), the size of body fat, and diabetes risk.
个体间生成新脂肪细胞的差异决定了体脂和 2 型糖尿病的风险。在 GENetics of Adipocyte Lipolysis (GENiAL) 队列中,对接受过腹部脂肪活检的参与者进行了一项脂肪细胞数量的全基因组关联研究(GWAS,n = 896)。从遗传研究中挑选出候选基因,通过 siRNA 在人脂肪源性干细胞中敲低。我们报告了 318 个单核苷酸多态性(SNP)和 17 个遗传位点,这些位点与脂肪细胞数量呈显著(P < 1 × 10-5)相关。两个位点通过了 GWAS 显著性的阈值,位于 2 号染色体(先导 SNP rs149660479-G)和 7 号染色体(rs147389390-缺失)。我们使用基因型特异性表达的证据对与脂肪细胞数量相关的 SNP(P < 1.00 × 10-5)进行了过滤。在观察到这种情况的地方,我们选择了基因进行后续调查,从而确定 SPATS2L 和 KCTD18 是与遗传数据一致的细胞增殖调节剂。此外,30 个报告的 2 型糖尿病相关 SNP 与脂肪细胞数量显示出名义上和一致的关联。在候选基因的功能后续研究中,RPL8、HSD17B12 和 PEPD 被确定为与遗传关联和基因表达发现一致的细胞增殖效应。总之,本文的研究结果确定了 SPATS2L、KCTD18、RPL8、HSD17B12 和 PEPD 在控制脂肪细胞数量(可塑性)、体脂肪大小和糖尿病风险方面具有潜在的重要性。